Provided by Tiger Fintech (Singapore) Pte. Ltd.

RenovoRx Inc

0.9501
+0.00010.01%
Volume:41.77K
Turnover:40.17K
Market Cap:34.72M
PE:-2.40
High:1.00
Open:0.9400
Low:0.9400
Close:0.9500
Loading ...

RenovoRx CMO Makes Bold Stock Purchase!

TIPRANKS
·
18 Apr

BRIEF-Renovorx Increases U.S. Production Of Renovocath Devices To Meet Growing Demand From Oncology Community

Reuters
·
16 Apr

RenovoRx Increases U.S. Production of RenovoCath® Devices to Meet Growing Demand from Oncology Community

Business Wire
·
16 Apr

Top Executives Make Bold Moves with RenovoRx Stock Purchases!

TIPRANKS
·
11 Apr

RenovoRx CMO Makes a Bold Move with Major Stock Purchase

TIPRANKS
·
10 Apr

RenovoRx Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Apr

RenovoRx Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
02 Apr

RenovoRx Delays Yearly Report Filing

TIPRANKS
·
01 Apr

RenovoRx Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
29 Mar

RenovoRx Highlights New Human Pharmacokinetic Data Abstract at SSO 2025 Annual Meeting

Business Wire
·
28 Mar

HC Wainwright Initiates Coverage on RenovoRx With Buy Rating, $3 Price Target

MT Newswires Live
·
27 Mar

RenovoRx, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $3

THOMSON REUTERS
·
27 Mar

RenovoRx Pre-Clinical Results Supporting TAMP™ as a Targeted Locoregional Drug Delivery Platform to Receive Award at SIR 2025 Annual Scientific Meeting

Business Wire
·
26 Mar

RenovoRx CEO to Provide Strategic Update During Fireside Chat on Thursday, April 3Rd at 12:00 P.m. Et

THOMSON REUTERS
·
20 Mar

RenovoRx CEO to Provide Strategic Update During Fireside Chat on Thursday, April 3rd at 12:00 p.m. ET

Business Wire
·
20 Mar

RenovoRx Advances Commercialization of RenovoCath® with Several New Purchase Orders, Including Customer Reorders

Business Wire
·
26 Feb

RenovoRx presents data from Trans-Arterial Micro-Perfusion therapy platform

TIPRANKS
·
13 Feb

RenovoRx Announces Closing of $12.1 Million Underwritten Public Offering of Common Stock

THOMSON REUTERS
·
11 Feb

RenovoRx Prices $12.1 Million Public Offering; Shares Decline Post-Announcement

GuruFocus.com
·
07 Feb

RenovoRx 11.52M share Spot Secondary priced at $1.05

TIPRANKS
·
07 Feb